List of Excipients in API BENDAMUSTINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BENDAMUSTINE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Baxter Healthcare Corporation | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | 10019-079 | ALCOHOL | |
| Baxter Healthcare Corporation | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | 10019-079 | MONOTHIOGLYCEROL | |
| Baxter Healthcare Corporation | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | 10019-079 | POLYETHYLENE GLYCOL 400 | |
| Baxter Healthcare Corporation | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | 10019-079 | SODIUM HYDROXIDE | |
| Eagle Pharmaceuticals Inc | BELRAPZO | bendamustine hydrochloride | 42367-521 | MONOTHIOGLYCEROL | |
| Eagle Pharmaceuticals Inc | BELRAPZO | bendamustine hydrochloride | 42367-521 | POLYETHYLENE GLYCOL 400 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BENDAMUSTINE HYDROCHLORIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Accord Healthcare Inc | bendamustine hydrochloride | 16729-250 | MANNITOL |
| Eugia US LLC | bendamustine hydrochloride | 55150-391 | MANNITOL |
| Apotex Corp | bendamustine hydrochloride | 60505-6095 | MANNITOL |
| BluePoint Laboratories | bendamustine hydrochloride | 68001-571 | MANNITOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BENDAMUSTINE HYDROCHLORIDE
Excipient focus: ALCOHOL
BENDAMUSTINE HYDROCHLORIDE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | bendamustine hydrochloride | 10019-079 |
| Apotex Corp | bendamustine hydrochloride | 60505-6228 |
| Slayback Pharma LLC | bendamustine hydrochloride | 71225-120 |
| >Company | >Ingredient | >NDC |
BENDAMUSTINE HYDROCHLORIDE drug variants not containing ALCOHOL
Excipient focus: MANNITOL
BENDAMUSTINE HYDROCHLORIDE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | bendamustine hydrochloride | 16729-250 |
| Eugia US LLC | bendamustine hydrochloride | 55150-391 |
| Apotex Corp | bendamustine hydrochloride | 60505-6095 |
| BluePoint Laboratories | bendamustine hydrochloride | 68001-571 |
| >Company | >Ingredient | >NDC |
BENDAMUSTINE HYDROCHLORIDE drug variants not containing MANNITOL
Excipient focus: MONOTHIOGLYCEROL
BENDAMUSTINE HYDROCHLORIDE drug variants containing MONOTHIOGLYCEROL
BENDAMUSTINE HYDROCHLORIDE drug variants not containing MONOTHIOGLYCEROL
Excipient focus: N,N-DIMETHYLACETAMIDE
BENDAMUSTINE HYDROCHLORIDE drug variants containing N,N-DIMETHYLACETAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Cephalon LLC | bendamustine hydrochloride | 63459-395 |
| >Company | >Ingredient | >NDC |
BENDAMUSTINE HYDROCHLORIDE drug variants not containing N,N-DIMETHYLACETAMIDE
Excipient focus: POLYETHYLENE GLYCOL
BENDAMUSTINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | bendamustine hydrochloride | 60505-6228 |
| >Company | >Ingredient | >NDC |
BENDAMUSTINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
BENDAMUSTINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400
BENDAMUSTINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: PROPYLENE GLYCOL
BENDAMUSTINE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Eagle Pharmaceuticals Inc | bendamustine hydrochloride | 42367-521 |
| Teva Pharmaceuticals USA Inc | bendamustine hydrochloride | 63459-348 |
| Cephalon LLC | bendamustine hydrochloride | 63459-395 |
| >Company | >Ingredient | >NDC |
BENDAMUSTINE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SODIUM HYDROXIDE
BENDAMUSTINE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
BENDAMUSTINE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
